Skip to content

The effects of using incentive spacer on the proper use of inhaler and asthma symptoms

comparison effects of incentive and ordinary spacer on the proper use of inhaler and Asthma control in children 10-5 years

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015122325627N3
Enrollment
38
Registered
2016-01-13
Start date
2015-01-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Asthmatic bronchitis NOSLate-onset asthma

Interventions

Intervention 1: In the control group (ordinary spacer): After obtaining informed consent from their parents, the eligible children will be randomly divided into intervention and control groups. Then t
Treatment - Devices
In the control group (ordinary spacer): After obtaining informed consent from their parents, the eligible children will be randomly divided into intervention and control groups. Then the ordinary spac
In the experimental group (incentive spacer): After obtaining informed consent parents of children, the eligible children will be randomly divided into intervention and control groups. Then the incent

Sponsors

Mashhad University of Medical Sciences, Research Deputy
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 10 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: children 5-10 years; living in mashhad and suburbs; Persian speaking; signing the informed consent form; no mental or psychological disorder (mental retardation) or physical disorders (visual and hearing impairments); developing asthma for the first time, according to the physician’s diagnosis; use of one inhaler (prescribed by the physician). Exclusion criteria: children withdrawn for any problems (traveling, moving, death); diagnosis of any underlying diseases except asthma (cardiovascular, immunodeficiency, digestive diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Proper Use of Spacer. Timepoint: Pre-test and post-test at the beginning of the Study and second post-test after one month. Method of measurement: Observational Check List.

Secondary

MeasureTime frame
Asthma Control. Timepoint: At the first session, c-ACT Post test at the end of a month after training session. Method of measurement: Asthma Control Test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSedighe Mande Kohnaky

Mashhad University of Medical Sciences

kohnakys911@mums.ac.ir+98 51 3841 2081

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026